Table 1.
All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021.
Fig 1.
APC of ASIR, ASPR, ASMR and ASDR for China RA from 1990 to 2021.
(a) ASIR;(b) ASPR;(C) ASMR;(d) ASDR.
Fig 2.
Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021.
(a) China; (b) Global.
Fig 3.
Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021.
(a) Number of incidence and CIR; (b) Number of prevalence and CPR; (c) Number of deaths and CMR; (d) Number of DALYs and CDR.
Fig 4.
Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 1990.
(a) Incidence;(b)Prevalence;(c) Deaths;(d) DALYs.
Fig 5.
Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021.
(a) Incidence;(b)Prevalence;(c) Deaths;(d) DALYs.
Fig 6.
Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021.
(a) Number of incidence and ASIR; (b) Number of prevalence and ASPR; (c) Number of deaths and ASMR; (d)Number of DALYs and ASMR.